Clinical Trials Logo

Classical Hodgkin's Lymphoma clinical trials

View clinical trials related to Classical Hodgkin's Lymphoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00742027 Completed - Clinical trials for Classical Hodgkin's Lymphoma

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Start date: September 16, 2008
Phase: Phase 2
Study type: Interventional

This study evaluated the efficacy of oral panobinostat in participants with refractory/relapsed classical Hodgkins lymphoma (HL) who have received prior treatment with high dose chemotherapy and autologous stem cell transplant. Safety of panobinostat also was assessed. Other markers that may correlate with efficacy or safety were explored.